🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/10/2022 | 58,98 | 58,98 | 57,47 | 57,68 | -1,76% | 2,56% | 127.599 |
| 07/10/2022 | 58,95 | 59,70 | 58,42 | 58,71 | -2,71% | 2,18% | 224.099 |
| 06/10/2022 | 59,34 | 60,92 | 59,34 | 60,35 | +2,22% | 2,66% | 194.604 |
| 05/10/2022 | 57,62 | 59,28 | 56,21 | 59,04 | +0,83% | 5,32% | 236.122 |
| 04/10/2022 | 54,97 | 58,63 | 54,97 | 58,55 | +7,85% | 6,66% | 329.256 |
| 03/10/2022 | 53,78 | 55,36 | 53,47 | 54,29 | +1,07% | 3,51% | 156.613 |
| 30/09/2022 | 53,82 | 55,85 | 53,62 | 53,72 | +0,63% | 4,13% | 193.322 |
| 29/09/2022 | 52,48 | 53,58 | 51,67 | 53,38 | +0,45% | 3,64% | 199.894 |
| 28/09/2022 | 50,75 | 53,43 | 50,75 | 53,14 | +6,22% | 5,27% | 194.123 |
| 27/09/2022 | 48,78 | 50,70 | 48,78 | 50,03 | +3,98% | 3,94% | 215.443 |
| 26/09/2022 | 50,28 | 51,34 | 47,79 | 48,12 | -4,92% | 7,06% | 253.434 |
| 23/09/2022 | 50,26 | 50,88 | 49,59 | 50,61 | -0,47% | 2,56% | 265.297 |
| 22/09/2022 | 51,67 | 51,67 | 50,41 | 50,84 | -2,03% | 2,43% | 193.963 |
| 21/09/2022 | 53,53 | 54,05 | 51,60 | 51,90 | -2,44% | 4,58% | 201.978 |
| 20/09/2022 | 53,49 | 53,72 | 52,71 | 53,19 | -1,55% | 1,89% | 166.552 |
| 19/09/2022 | 54,62 | 54,98 | 52,60 | 54,03 | -1,41% | 4,37% | 252.152 |
| 16/09/2022 | 55,45 | 55,45 | 53,11 | 54,80 | -2,53% | 4,23% | 1.027.683 |
| 15/09/2022 | 55,83 | 56,65 | 55,43 | 56,23 | +0,69% | 2,18% | 250.228 |
| 14/09/2022 | 57,02 | 57,29 | 55,13 | 55,84 | -1,64% | 3,80% | 252.793 |
| 13/09/2022 | 57,25 | 58,15 | 56,15 | 56,77 | -4,10% | 3,49% | 275.235 |
| 12/09/2022 | 60,20 | 60,20 | 58,53 | 59,20 | -1,26% | 2,77% | 155.331 |
| 09/09/2022 | 60,16 | 60,42 | 59,58 | 59,95 | +0,34% | 1,39% | 132.087 |
| 08/09/2022 | 58,17 | 60,10 | 57,84 | 59,74 | +2,18% | 3,88% | 150.041 |
| 07/09/2022 | 56,42 | 58,47 | 56,42 | 58,47 | +3,74% | 3,64% | 205.344 |
| 06/09/2022 | 58,45 | 59,51 | 56,17 | 56,36 | -3,77% | 5,71% | 211.756 |
| 02/09/2022 | 59,60 | 60,65 | 58,00 | 58,57 | -0,19% | 4,45% | 184.986 |
| 01/09/2022 | 57,43 | 58,78 | 56,52 | 58,68 | +1,82% | 3,93% | 172.002 |
| 31/08/2022 | 58,90 | 59,27 | 57,50 | 57,64 | -0,71% | 3,01% | 170.399 |
| 30/08/2022 | 60,38 | 60,65 | 56,31 | 58,05 | -3,62% | 7,19% | 200.054 |
| 29/08/2022 | 60,54 | 61,73 | 60,01 | 60,22 | -2,22% | 2,85% | 175.849 |